Correlation Between Parker Hannifin and Apogee Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Parker Hannifin and Apogee Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Parker Hannifin and Apogee Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Parker Hannifin and Apogee Therapeutics, Common, you can compare the effects of market volatilities on Parker Hannifin and Apogee Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Parker Hannifin with a short position of Apogee Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Parker Hannifin and Apogee Therapeutics,.

Diversification Opportunities for Parker Hannifin and Apogee Therapeutics,

0.15

Correlation Coefficient

Parker Hannifin  Apogee Therapeutics,

Average diversification

The 3 months correlation between Parker and Apogee is 0.15. Overlapping area represents the amount of risk that can be diversified away by holding Parker Hannifin and Apogee Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apogee Therapeutics, and Parker Hannifin is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Parker Hannifin are associated (or correlated) with Apogee Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apogee Therapeutics, has no effect on the direction of Parker Hannifin i.e., Parker Hannifin and Apogee Therapeutics, go up and down completely randomly.

Pair Corralation between Parker Hannifin and Apogee Therapeutics,

Allowing for the 90-day total investment horizon Parker Hannifin is expected to generate 0.31 times more return on investment than Apogee Therapeutics,. However, Parker Hannifin is 3.21 times less risky than Apogee Therapeutics,. It trades about 0.21 of its potential returns per unit of risk. Apogee Therapeutics, Common is currently generating about 0.04 per unit of risk. If you would invest  61,220  in Parker Hannifin on May 6, 2025 and sell it today you would earn a total of  9,993  from holding Parker Hannifin or generate 16.32% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Parker Hannifin  vs.  Apogee Therapeutics, Common

Parker Hannifin

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Parker Hannifin are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite fairly abnormal technical indicators, Parker Hannifin demonstrated solid returns over the last few months and may actually be approaching a breakup point.

Apogee Therapeutics,

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Apogee Therapeutics, Common are ranked lower than 3 (%) of all global equities and portfolios over the last 90 days. In spite of rather conflicting technical and fundamental indicators, Apogee Therapeutics, may actually be approaching a critical reversion point that can send shares even higher in September 2025.

Pair Trading with Parker Hannifin and Apogee Therapeutics,

The main advantage of trading using opposite Parker Hannifin and Apogee Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Parker Hannifin position performs unexpectedly, Apogee Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apogee Therapeutics, will offset losses from the drop in Apogee Therapeutics,'s long position.

The idea behind Parker Hannifin and Apogee Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Risk-Return Analysis module to view associations between returns expected from investment and the risk you assume.